Stephen J Wort Selected Research

Eisenmenger Complex (Eisenmenger's Syndrome)

10/2021	Impact of cyanosis on ventilatory responses during stair climb exercise in Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
1/2020	A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study.
10/2013	Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome.
8/2013	Disease targeting therapies in patients with Eisenmenger syndrome: response to treatment and long-term efficiency.
5/2012	B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy.
1/2010	Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen J Wort Research Topics

Disease

19	Pulmonary Arterial Hypertension 01/2022 - 09/2009
11	Pulmonary Hypertension 01/2019 - 11/2002
6	Eisenmenger Complex (Eisenmenger's Syndrome) 10/2021 - 01/2010
6	Congenital Heart Defects (Congenital Heart Defect) 01/2019 - 01/2010
3	Hypoxia (Hypoxemia) 02/2014 - 03/2009
3	Vascular Remodeling 02/2014 - 11/2002
2	Hemorrhage 01/2021 - 10/2020
2	Right Ventricular Dysfunction 10/2020 - 01/2010
2	Hypertension (High Blood Pressure) 01/2018 - 07/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 03/2009
2	Inflammation (Inflammations) 09/2015 - 08/2014
1	Ischemic Stroke 01/2021
1	Aortic Coarctation 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020
1	Lung Diseases (Lung Disease) 10/2020
1	Disease Susceptibility (Diathesis) 01/2020
1	Pulmonary Embolism 02/2019
1	Heart Failure 01/2019
1	Channelopathies 10/2018
1	Cyanosis 09/2018
1	Atrophy 01/2018
1	Hypertrophy 01/2018
1	Sarcopenia 01/2018
1	Rare Diseases (Rare Disease) 11/2017
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2017
1	Lymphadenopathy 11/2017
1	Neoplasms (Cancer) 10/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Liver Diseases (Liver Disease) 05/2015
1	Infections 09/2014
1	Down Syndrome (Down's Syndrome) 09/2014
1	Familial Primary Pulmonary Hypertension 08/2014
1	Idiopathic Interstitial Pneumonias 07/2014
1	Sarcoidosis (Schaumann Disease) 01/2011
1	Pulmonary Sarcoidosis 01/2011
1	Cardiomegaly (Heart Hypertrophy) 03/2010

Drug/Important Bio-Agent (IBA)

5	Endothelin-1 (Endothelin 1)IBA 02/2014 - 11/2002
3	Oxygen (Dioxygen)IBA 10/2021 - 01/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 05/2012
2	MonocrotalineIBA 01/2020 - 09/2015
2	IronIBA 09/2018 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2017
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2017 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 01/2006
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 03/2010 - 11/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ProteomeIBA 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 10/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 10/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Iloprost (Ventavis)FDA Link 01/2020
1	AnticoagulantsIBA 02/2019
1	HLA-DPA1 antigen (HLA DPA1)IBA 01/2019
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019
1	PotassiumIBA 10/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018
1	Prokaryotic Initiation Factor-2IBA 11/2017
1	Carbon MonoxideIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Adenosine Triphosphate (ATP)IBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 10/2017
1	Biological ProductsIBA 07/2017
1	Metal-Organic FrameworksIBA 07/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Platelet-Derived Growth FactorIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	SodiumIBA 05/2015
1	CreatinineIBA 05/2015
1	C-Reactive ProteinIBA 09/2014
1	AlarminsIBA 08/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	InterleukinsIBA 08/2014
1	Interleukin-33IBA 08/2014
1	Bosentan (Tracleer)FDA Link 07/2014
1	Interferon Type IIBA 02/2014
1	InterferonsIBA 02/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2012
1	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2012
1	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 03/2010
1	PPAR-betaIBA 03/2010
1	Phosphodiesterase 5 InhibitorsIBA 03/2010
1	Endothelin Receptor AntagonistsIBA 03/2010
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2010

Therapy/Procedure

14	Therapeutics 10/2020 - 11/2002
2	Critical Care (Surgical Intensive Care) 01/2010 - 01/2006
1	Thrombolytic Therapy 10/2020
1	Transplantation 01/2019
1	Heart-Lung Transplantation 01/2019
1	Endarterectomy (Thromboendarterectomy) 05/2016
1	Perioperative Period 05/2016
1	Blood Transfusion (Blood Transfusions) 09/2014
1	Lung Transplantation 01/2011
1	Cardiac Catheters 01/2011